These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29981090)

  • 21. [Cardiovascular risks and management during Attention Deficit Hyperactivity Disorder treatment with methylphenidate].
    Bange F; Le Heuzey MF; Acquaviva E; Delorme R; Mouren MC
    Arch Pediatr; 2014 Jan; 21(1):108-12. PubMed ID: 24309201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
    Hammerness PG; Perrin JM; Shelley-Abrahamson R; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):978-90. PubMed ID: 21961773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention deficit disorder, stimulant use, and childhood body mass index trajectory.
    Schwartz BS; Bailey-Davis L; Bandeen-Roche K; Pollak J; Hirsch AG; Nau C; Liu AY; Glass TA
    Pediatrics; 2014 Apr; 133(4):668-76. PubMed ID: 24639278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL; Bipath P; van der Westhuizen D; Viljoen M
    Neuropsychobiology; 2011; 63(2):82-91. PubMed ID: 21178382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
    Hammerness PG; Karampahtsis C; Babalola R; Alexander ME
    Expert Opin Drug Saf; 2015 Apr; 14(4):543-51. PubMed ID: 25648243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and Management of Elevated Blood Pressure in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
    Yamaguchi I; Hanevold C
    Curr Hypertens Rep; 2019 Jun; 21(8):60. PubMed ID: 31218513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is adjunctive pharmacotherapy in attention-deficit/hyperactivity disorder cost-effective in Canada: a cost-effectiveness assessment of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant for the treatment of ADHD.
    Lachaine J; Sikirica V; Mathurin K
    BMC Psychiatry; 2016 Jan; 16():11. PubMed ID: 26774811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Stimulant Medication Use on Heart Rate and Systolic Blood Pressure During Submaximal Exercise Treadmill Testing in Adolescents.
    Westover AN; Nakonezny PA; Adinoff B; Brown ES; Halm EA
    J Child Adolesc Psychopharmacol; 2016 Dec; 26(10):889-899. PubMed ID: 27626945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.
    Stein MA; Sarampote CS; Waldman ID; Robb AS; Conlon C; Pearl PL; Black DO; Seymour KE; Newcorn JH
    Pediatrics; 2003 Nov; 112(5):e404. PubMed ID: 14595084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
    Wilens TE; Zusman RM; Hammerness PG; Podolski A; Whitley J; Spencer TJ; Gignac M; Biederman J
    J Clin Psychiatry; 2006 May; 67(5):696-702. PubMed ID: 16841618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The longitudinal influence of ADHD status and stimulant medication on body mass index and blood pressure among youth with obesity.
    Kollin SR; Lim CS; Lee AA
    Pediatr Obes; 2023 Sep; 18(9):e13058. PubMed ID: 37263740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study.
    Wilens TE; Biederman J; Lerner M;
    J Clin Psychopharmacol; 2004 Feb; 24(1):36-41. PubMed ID: 14709945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of Methylphenidate and Atomoxetine on Heart Rate and Systolic Blood Pressure in Young People and Adults with Attention-Deficit Hyperactivity Disorder (ADHD): Systematic Review, Meta-Analysis, and Meta-Regression.
    Liang EF; Lim SZ; Tam WW; Ho CS; Zhang MW; McIntyre RS; Ho RC
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe.
    Coghill DR; Banaschewski T; Nagy P; Otero IH; Soutullo C; Yan B; Caballero B; Zuddas A
    CNS Drugs; 2017 Jul; 31(7):625-638. PubMed ID: 28667569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of stimulant and non-stimulant medications on the autonomic nervous system (ANS) functioning in people with ADHD: A systematic review and meta-analysis.
    Idrees I; Bellato A; Cortese S; Groom MJ
    Neurosci Biobehav Rev; 2023 Jan; 144():104968. PubMed ID: 36427764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of stimulants on sleep characteristics in children with attention deficit/hyperactivity disorder.
    O'Brien LM; Ivanenko A; Crabtree VM; Holbrook CR; Bruner JL; Klaus CJ; Gozal D
    Sleep Med; 2003 Jul; 4(4):309-16. PubMed ID: 14592303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.